Skip to main content

Medicines Shouldn't Be a Luxury

Medicines Shouldn't Be a Luxury

On March 27th, 2017 The international medical humanitarian organisation Médecins Sans Frontières (MSF) filed a patent challenge on the Hepatitis C drug Sofosbuvir with the European Patent Office (EPO) in an effort to increase access to affordable Hepatitis C treatment.  MSF has joined Médecins du Monde (MdM) and other civil society organisations from 17 countries in simultaneously filing patent challenges on the pharmaceutical corporation Gilead’s monopoly on Sofosbuvir, in a bid to remove the barriers that prevent millions of people receiving treatment.
 
You can read the full article by clicking here.
 
 
Share

World Refugee Day - It's Her Turn

Jun 17, 2020

June 20th marks World Refugee Day. For millions of women and girls among the world’s ever-growing refugee population, education remains an aspiration, not a reality.  In Africa, COVID-19 is... Read more